New registry to track MG drug safety in 1,500 patients
NCT ID NCT07217509
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry will follow about 1,500 adults with myasthenia gravis (MG) to see how well current treatments work and how safe they are in real life. Doctors and patients will report data during routine visits. The goal is to better understand the disease and improve care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could help doctors better understand how myasthenia gravis progresses and which treatments work best in everyday practice.
What could go wrong
This is an observational study, not a treatment trial. It collects data only, so it won't directly test or prove any new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States